Suspension of trading
Valuation ICAD
Stocks
ICAD
US44934S2068
Advanced Medical Equipment & Technology
|
Market Closed -
Nasdaq
06:00:00 17/07/25 am AEST
|
5-day change | 1st Jan Change | ||
| 3.870 USD | +3.75% |
|
-.--% | - |
| 21/07/25 | ICAD, Inc.(NasdaqCM:ICAD) dropped from S&P TMI Index | CI |
| 18/07/25 | ICAD, Inc.(NasdaqCM:ICAD) dropped from Russell Microcap Value Benchmark Index | CI |
Company Valuation: ICAD
Data adjusted to current consolidation scope
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 150.4 | 303.5 | 180.8 | 46.57 | 46.64 | 48.23 |
| Change | - | 101.77% | -40.43% | -74.24% | 0.17% | 3.4% |
| Enterprise Value (EV) 1 | 157.6 | 285.1 | 147.7 | 28.64 | 25.44 | 31.38 |
| Change | - | 80.89% | -48.2% | -80.6% | -11.19% | 23.39% |
| P/E | -10.5x | -16.5x | -15.9x | -3.38x | -9.35x | -8.59x |
| PBR | 29.7x | 10.2x | 3.89x | 1.32x | 1.4x | 1.68x |
| PEG | - | -2.04x | 0.4x | -0.2x | 0.1x | -0.7x |
| Capitalization / Revenue | 4.8x | 10.2x | 5.37x | 1.67x | 2.69x | 2.46x |
| EV / Revenue | 5.03x | 9.6x | 4.39x | 1.02x | 1.47x | 1.6x |
| EV / EBITDA | -27.5x | -32.4x | -14.5x | -2.14x | -3.49x | -5.75x |
| EV / EBIT | -24.6x | -30.4x | -13.8x | -2.06x | -3.31x | -5.16x |
| EV / FCF | -30.3x | -131x | -21.4x | -3.13x | -12.1x | -9.62x |
| FCF Yield | -3.3% | -0.76% | -4.66% | -31.9% | -8.29% | -10.4% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -0.74 | -0.8 | -0.4538 | -0.5419 | -0.1892 | -0.2131 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 31.34 | 29.7 | 33.64 | 27.94 | 17.32 | 19.61 |
| EBITDA 1 | -5.723 | -8.811 | -10.18 | -13.41 | -7.28 | -5.46 |
| EBIT 1 | -6.397 | -9.388 | -10.73 | -13.93 | -7.689 | -6.084 |
| Net income 1 | -13.55 | -17.61 | -11.24 | -13.66 | -4.847 | -5.616 |
| Net Debt 1 | 7.177 | -18.42 | -33.13 | -17.93 | -21.21 | -16.84 |
| Reference price 2 | 7.770 | 13.200 | 7.200 | 1.830 | 1.770 | 1.830 |
| Nbr of stocks (in thousands) | 19,359 | 22,993 | 25,109 | 25,446 | 26,353 | 26,354 |
| Announcement Date | 11/3/20 | 15/3/21 | 29/3/22 | 31/3/23 | 29/3/24 | 31/3/25 |
1USD in Million2USD
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 106M | |
| 29.3x | 5.21x | 19.96x | 0.31% | 218B | |
| 33.93x | 6.16x | 19.53x | 0.72% | 142B | |
| 43.29x | 11.28x | 24.94x | -.--% | 139B | |
| 19.38x | 3.92x | 12.75x | -.--% | 75.11B | |
| 36.2x | 7.27x | 23.01x | -.--% | 52.8B | |
| 19.6x | 2.34x | 11.74x | 2.6% | 50.66B | |
| 28.88x | 5.77x | 19.7x | 0.69% | 41.95B | |
| 88.04x | 6.88x | 20.88x | -.--% | 40.49B | |
| 15.78x | 1.81x | 10.11x | 0.22% | 33.28B | |
| Average | 34.93x | 5.63x | 18.07x | 0.5% | 79.36B | |
| Weighted average by Cap. | 33.90x | 6.25x | 19.37x | 0.43% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ICAD Stock
- Valuation ICAD
Select your edition
All financial news and data tailored to specific country editions
